100 related articles for article (PubMed ID: 9041661)
1. Antibodies to OspB prevent infection of C3H mice challenged with Borrelia burgdorferi isolates expressing truncated OspB antigens.
Probert WS; Crawford M; LeFebvre RB
Vaccine; 1997 Jan; 15(1):15-9. PubMed ID: 9041661
[TBL] [Abstract][Full Text] [Related]
2. Evasion of protective immunity by Borrelia burgdorferi by truncation of outer surface protein B.
Fikrig E; Tao H; Kantor FS; Barthold SW; Flavell RA
Proc Natl Acad Sci U S A; 1993 May; 90(9):4092-6. PubMed ID: 7683420
[TBL] [Abstract][Full Text] [Related]
3. Identification of a highly cross-reactive outer surface protein B epitope among diverse geographic isolates of Borrelia spp. causing Lyme disease.
Shoberg RJ; Jonsson M; Sadziene A; Bergström S; Thomas DD
J Clin Microbiol; 1994 Feb; 32(2):489-500. PubMed ID: 7512097
[TBL] [Abstract][Full Text] [Related]
4. Immune sera to individual Borrelia burgdorferi isolates or recombinant OspA thereof protect SCID mice against infection with homologous strains but only partially or not at all against those of different OspA/OspB genotype.
Schaible UE; Wallich R; Kramer MD; Gern L; Anderson JF; Museteanu C; Simon MM
Vaccine; 1993; 11(10):1049-54. PubMed ID: 8212826
[TBL] [Abstract][Full Text] [Related]
5. Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not with OspD or the 83-kilodalton antigen.
Probert WS; LeFebvre RB
Infect Immun; 1994 May; 62(5):1920-6. PubMed ID: 8168958
[TBL] [Abstract][Full Text] [Related]
6. Borrelia burgdorferi antigens that are targeted by antibody-dependent, complement-mediated killing in the rhesus monkey.
Aydintug MK; Gu Y; Philipp MT
Infect Immun; 1994 Nov; 62(11):4929-37. PubMed ID: 7927774
[TBL] [Abstract][Full Text] [Related]
7. Selection of variant Borrelia burgdorferi isolates from mice immunized with outer surface protein A or B.
Fikrig E; Tao H; Barthold SW; Flavell RA
Infect Immun; 1995 May; 63(5):1658-62. PubMed ID: 7729870
[TBL] [Abstract][Full Text] [Related]
8. A bactericidal antibody to Borrelia burgdorferi is directed against a variable region of the OspB protein.
Sadziene A; Jonsson M; Bergström S; Bright RK; Kennedy RC; Barbour AG
Infect Immun; 1994 May; 62(5):2037-45. PubMed ID: 7513309
[TBL] [Abstract][Full Text] [Related]
9. Variations in the ospB gene of Borrelia burgdorferi result in differences in monoclonal antibody reactivity and in production of escape variants.
Coleman JL; Rogers RC; Rosa PA; Benach JL
Infect Immun; 1994 Jan; 62(1):303-7. PubMed ID: 7505260
[TBL] [Abstract][Full Text] [Related]
10. Vaccination against Lyme disease caused by diverse Borrelia burgdorferi.
Fikrig E; Telford SR; Wallich R; Chen M; Lobet Y; Matuschka FR; Kimsey RB; Kantor FS; Barthold SW; Spielman A; Flavell RA
J Exp Med; 1995 Jan; 181(1):215-21. PubMed ID: 7807004
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous implanted chambers in different mouse strains as an animal model to study genetic stability during infection with Lyme disease Borrelia.
Jonsson M; Elmros T; Bergström S
Microb Pathog; 1995 Feb; 18(2):109-14. PubMed ID: 7543971
[TBL] [Abstract][Full Text] [Related]
12. Outer surface protein B is critical for Borrelia burgdorferi adherence and survival within Ixodes ticks.
Neelakanta G; Li X; Pal U; Liu X; Beck DS; DePonte K; Fish D; Kantor FS; Fikrig E
PLoS Pathog; 2007 Mar; 3(3):e33. PubMed ID: 17352535
[TBL] [Abstract][Full Text] [Related]
13. Impact of the saponin adjuvant QS-21 and aluminium hydroxide on the immunogenicity of recombinant OspA and OspB of Borrelia burgdorferi.
Ma J; Bulger PA; Davis DR; Perilli-Palmer B; Bedore DA; Kensil CR; Young EM; Hung CH; Seals JR; Pavia CS
Vaccine; 1994 Aug; 12(10):925-32. PubMed ID: 7975834
[TBL] [Abstract][Full Text] [Related]
14. An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi.
Luke CJ; Carner K; Liang X; Barbour AG
J Infect Dis; 1997 Jan; 175(1):91-7. PubMed ID: 8985201
[TBL] [Abstract][Full Text] [Related]
15. Characterization of canine humoral immune responses to outer surface protein subunit vaccines and to natural infection by Lyme disease spirochetes.
Ma J; Bulger PA; Dante S; Davis DR; Perilli-Palmer B; Coughlin RT
J Infect Dis; 1995 Apr; 171(4):909-15. PubMed ID: 7706819
[TBL] [Abstract][Full Text] [Related]
16. Protection of dogs from Lyme disease with a vaccine containing outer surface protein (Osp) A, OspB, and the saponin adjuvant QS21.
Coughlin RT; Fish D; Mather TN; Ma J; Pavia C; Bulger P
J Infect Dis; 1995 Apr; 171(4):1049-52. PubMed ID: 7706788
[TBL] [Abstract][Full Text] [Related]
17. Sera from patients with chronic Lyme disease protect mice from Lyme borreliosis.
Fikrig E; Bockenstedt LK; Barthold SW; Chen M; Tao H; Ali-Salaam P; Telford SR; Flavell RA
J Infect Dis; 1994 Mar; 169(3):568-74. PubMed ID: 8158028
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of neutralizing epitopes on outer surface proteins A and B of Borrelia burgdorferi.
Ma J; Gingrich-Baker C; Franchi PM; Bulger P; Coughlin RT
Infect Immun; 1995 Jun; 63(6):2221-7. PubMed ID: 7539408
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies with in vitro borreliacidal activities define the outer surface proteins A and B of Borrelia burgdorferi.
Moskophidis M; Luther B
Zentralbl Bakteriol; 1993 Jun; 279(2):201-13. PubMed ID: 8219491
[TBL] [Abstract][Full Text] [Related]
20. An OspB mutant of Borrelia burgdorferi has reduced invasiveness in vitro and reduced infectivity in vivo.
Sadziene A; Barbour AG; Rosa PA; Thomas DD
Infect Immun; 1993 Sep; 61(9):3590-6. PubMed ID: 8359881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
